AK

Anand Kumar

Active Director Director DIN 10479575
DIN 10479575 First appointment Jan 2024 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Anand Kumar

Data last updated:

Anand Kumar is a Director at Radiate Pharma Private Limited (since 2024). The company operates in Trading. Radiate Pharma Private Limited reported revenue of ₹52.1 Lakh (FY 2025).

DIN 10479575
Primary Designation Director
Industry Trading
First Appointment 25 Jan 2024
Oldest Company Age 10 yrs
Largest company Radiate Pharma Private Limited · ₹52.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radiate Pharma Private Limited U51909DL2016PTC291400
Director25 Jan 20242016₹52.1 Lakh (FY 2025)Active

Board colleagues of Anand Kumar

NameDINCompanyDesignation
Prashant Dhankar10478338Radiate Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Radiate Pharma Private Limited
Premium access

Shareholding and investment profile for Anand Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Kumar

Anand Kumar currently holds 1 directorship: Radiate Pharma Private Limited (Director, since 25 Jan 2024, revenue ₹52.1 Lakh (FY 2025)).

Anand Kumar was first appointed on 25 Jan 2024 as Director at Radiate Pharma Private Limited.

The current boards of Anand Kumar's companies include Prashant Dhankar (Radiate Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available